Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Precision Cancer Research LLC

Neither a doctor nor a teaching hospital

Research payments

$1,642,086

584 payments

Through program year 2025, Precision Cancer Research LLC is reported as receiving $1,642,086 in research payments, across 584 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $36,661 5
2024 Research $53,305 21
2023 Research $76,099 27
2022 Research $213,268 86
2021 Research $401,740 142
2020 Research $669,495 213
2019 Research $191,518 90

Breakdown

Who paid Research payments · program years 2019–2025
  1. Daiichi Sankyo Inc. $654,404 244 payments
  2. Radius Health, Inc. $369,745 95 payments
  3. Exelixis Inc. $350,421 66 payments
  4. BeiGene, Ltd. $77,107 50 payments
  5. Bayer HealthCare Pharmaceuticals Inc. $40,054 58 payments
  6. Pfizer Inc. $30,719 17 payments
  7. Ferring International Pharmascience Center US $22,474 14 payments
  8. AstraZeneca UK Limited $20,295 3 payments
  9. AstraZeneca Pharmaceuticals LP $20,292 4 payments
  10. Ferring Pharmaceuticals AS $20,086 14 payments
Studies the money was for Research payments · program years 2019–2025
  1. A Randomized, Multicenter, Phase 2 Study Of Elacestrant (rad1901) Versus Investigators Choice Of Fulvestrant Or Aromatase Inhibitor Therapy For The Treatment Of Postmenopausal Women With Er+/her2- Breast Cancer $303,757 63 payments
  2. Ds8201-A-U302 $225,890 58 payments
  3. Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors $213,952 43 payments
  4. Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors $102,322 20 payments
  5. Ds8201-A-U302 $76,007 16 payments
  6. Ds8201-A-U301 $60,954 16 payments
  7. Study name not reported $60,577 27 payments
  8. Study name not reported $55,079 30 payments
  9. Study name not reported $54,367 36 payments
  10. Ds8201-A-U301 $51,700 25 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record